Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course

Clinical trial NCT00967512 · WITHDRAWN

Trial details

NCT number: NCT00967512
Sponsor: Eleos, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia

Start date: 2012-01-01
Primary completion: 2012-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.